3:10 Development of a Single Dose Vaccine Against COVID-19 Using GV-MVA-VLP Vector Platform
Farshad Guirakhoo, PhD, CSO, GeoVax
In only a few months, the emerging COVID-19 has caused a global pandemic, killed hundreds of thousands, and crippled the global economy. A safe and effective vaccine to control this new pathogen is desperately needed. We have leveraged our unique, safe, live viral GV-MVA-VLP™ platform to develop multiple vaccine candidates against COVID-19. These will be down selected to one in appropriate challenge models for safety and efficacy before entering into humans